TNF Pharmaceuticals Statistics Share Statistics TNF Pharmaceuticals has 1.77M
shares outstanding. The number of shares has increased by 498.38%
in one year.
Shares Outstanding 1.77M Shares Change (YoY) 498.38% Shares Change (QoQ) 414.83% Owned by Institutions (%) 3.69% Shares Floating 20.9M Failed to Deliver (FTD) Shares 152,367 FTD / Avg. Volume 24.75%
Short Selling Information The latest short interest is 5.72M, so 320.5% of the outstanding
shares have been sold short.
Short Interest 5.72M Short % of Shares Out 320.5% Short % of Float 320.56% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.12 and the forward
PE ratio is null.
TNF Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.12 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.19 P/FCF Ratio -0.31 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for TNF Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.4,
with a Debt / Equity ratio of 0.
Current Ratio 1.4 Quick Ratio 1.4 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-11.68M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -97.38% in the
last 52 weeks. The beta is 2.28, so TNF Pharmaceuticals's
price volatility has been higher than the market average.
Beta 2.28 52-Week Price Change -97.38% 50-Day Moving Average 8.05 200-Day Moving Average 41.58 Relative Strength Index (RSI) 33 Average Volume (20 Days) 615,698
Income Statement
Revenue n/a Gross Profit n/a Operating Income -10.17M Net Income -23.36M EBITDA -23.36M EBIT -23.36M Earnings Per Share (EPS) -1115
Full Income Statement Balance Sheet The company has 173.15K in cash and 10.58K in
debt, giving a net cash position of 162.57K.
Cash & Cash Equivalents 173.15K Total Debt 10.58K Net Cash 162.57K Retained Earnings -129.14M Total Assets 17.15M Working Capital -397.58K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.98M
and capital expenditures -3, giving a free cash flow of -8.98M.
Operating Cash Flow -8.98M Capital Expenditures -3 Free Cash Flow -8.98M FCF Per Share -368.34
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields TNFA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for TNFA.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 2, 2025. It was a
backward
split with a ratio of 1:100.
Last Split Date Sep 2, 2025 Split Type backward Split Ratio 1:100
Scores Altman Z-Score -11.85 Piotroski F-Score 0
